clinical trial · NCT05198245
Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
Pfizer·—·active not recruiting·n = 1
MigraineRimegepantVariousNo intervention
brief summary
The purpose of the study is to evaluate the risk of pregnancy and infant outcomes among women with migraine exposed to rimegepant during pregnancy and in two rimegepant unexposed comparator groups.
started
Dec 15, 2021
primary completion
Apr 17, 2028
completion
Apr 17, 2028
last updated
Jan 8, 2026
official title
Retrospective Cohort Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol